Wednesday, June 08, 2005
Cancer test developer Diagnocure widens Q2 net loss to $626,859 from $170,370
QUEBEC (CP) - Diagnocure Inc., a cancer test developer, widened its losses in the latest quarter on higher expenses and stock compensation charges....More
Subscribe to:
Post Comments (Atom)
Posts
No comments:
Post a Comment